Physician profile
Deepake Bakane
NPI 1780766097
$1,784.52
in general payments reported to CMS, 2019-2025
14 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $198 · 2021: $251 · 2022: $255 · 2023: $157 · 2024: $267 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $474.15 | 2019-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $379.41 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Inspire Medical Systems, INC. | $250.46 | 2024-2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $203.51 | 2019-2023 | Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $100.03 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $90.23 | 2025 | Assure Wcd |
| Novo Nordisk INC | $82.90 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $62.69 | 2022 | |
| Axsome Therapeutics, INC. | $43.30 | 2025 | Symbravo |
| Exact Sciences Corporation | $35.37 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $18.00 | 2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $16.59 | 2020 | |
| Amneal Pharmaceuticals LLC | $14.19 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.69 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepake Bakane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.